Medco: Market Multiplier for Personalized Medicine
Executive Summary
Medco is developing data that could accelerate the adoption of personalized medicine--as a way to make itself more relevant to customers and the lives they represent. Armed with infrastructure from its mail pharmacy business and access to medical information on large groups of people, it is financing and conducting studies to show the value of pharmacogenomic tests in improving clinical outcomes. By so doing, it could become an incredible enabler of companies pursuing personalized medicine.
You may also be interested in...
Express Scripts-Medco Deal Showcases New Post-Health Reform Reality
Express Scripts' merger agreement with Medco Health Solutions to form a mega-pharmacy benefits manager fits the new realities of the post-health care reform world. Together, the two PBMs managed more than 1.7 billion prescription claims for approximately 135 million individuals in 2010; thus, the tie-up, which was announced July 21, creates an entity that dominates the PBM space by a wide margin, with CVS Caremark the only other major competitor.
Express Scripts-Medco Deal Showcases New Post-Health Reform Reality
Express Scripts' merger agreement with Medco Health Solutions to form a mega-pharmacy benefits manager fits the new realities of the post-health care reform world. Together, the two PBMs managed more than 1.7 billion prescription claims for approximately 135 million individuals in 2010; thus, the tie-up, which was announced July 21, creates an entity that dominates the PBM space by a wide margin, with CVS Caremark the only other major competitor.
Medco Buys DNA Direct To Bolster Personalized Medicine Business
Medco's purchase of DNA Direct, announced Feb. 2, will enable the pharmacy benefits manager to grow its personalized medicine business by adding decision support services for payors, providers and patients